U.S. Most Lenient in Prescribing Puberty Blockers and Hormones to Children

In a recent report, “Do No Harm,” a group of healthcare professionals and policymakers, claims that the United States is the most lenient country in terms of prescribing puberty blockers and cross-sex hormones to children.

The report, titled “Reassigned,” says that “extreme gender ideology drives the United States to provide transgender medical care to younger children, while Europe goes a safer and more scientific route.”

The study compared the policies of the U.S. with those of 11 western and northern European countries. It found that while some states in the U.S. restrict minors’ access to sex reassignment surgery, double mastectomies have been performed on girls as young as 12.

In contrast, more than half of the European countries examined in the research have set the minimum age for sex change surgeries to 18.

Dr. Michelle Cretella, executive director of the American College of Pediatricians, says, the US “is the most permissive country when it comes to pushing gender ideology and prescribing puberty blockers and cross-sex hormones to children.”

“This is a serious public health issue that is being ignored and even promoted by powerful institutions and organizations,” Cretella added.

The report also concludes that the U.S. has much looser age restrictions for prescribing cross-sex hormones than European countries.

For example, Oregon has the lowest minimum age requirement for obtaining cross-sex hormones, which stands at 15.

In comparison, in most European countries, trans-identified youth must be at least 16 to gain access to cross-sex hormones.

The report attributes this difference to the fact that the belief that biological sex and gender are socially constructed has infiltrated American classrooms, courtrooms, bathrooms, and boardrooms.